176 related articles for article (PubMed ID: 24912680)
1. Cyclin D1 and C/EBPβ LAP1 operate in a common pathway to promote mammary epithelial cell differentiation.
Liu Q; Boudot A; Ni J; Hennessey T; Beauparlant SL; Rajabi HN; Zahnow C; Ewen ME
Mol Cell Biol; 2014 Aug; 34(16):3168-79. PubMed ID: 24912680
[TBL] [Abstract][Full Text] [Related]
2. Expression of the CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins.
Milde-Langosch K; Löning T; Bamberger AM
Breast Cancer Res Treat; 2003 May; 79(2):175-85. PubMed ID: 12825852
[TBL] [Abstract][Full Text] [Related]
3. Expression and function of CCAAT/enhancer binding proteinbeta (C/EBPbeta) LAP and LIP isoforms in mouse mammary gland, tumors and cultured mammary epithelial cells.
Dearth LR; Hutt J; Sattler A; Gigliotti A; DeWille J
J Cell Biochem; 2001; 82(3):357-70. PubMed ID: 11500913
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor stimulation activates the RNA binding protein CUG-BP1 and increases expression of C/EBPbeta-LIP in mammary epithelial cells.
Baldwin BR; Timchenko NA; Zahnow CA
Mol Cell Biol; 2004 May; 24(9):3682-91. PubMed ID: 15082764
[TBL] [Abstract][Full Text] [Related]
5. LIP expression is regulated by IGF-1R signaling and participates in suppression of anoikis.
Li H; Baldwin BR; Zahnow CA
Mol Cancer; 2011 Aug; 10():100. PubMed ID: 21854628
[TBL] [Abstract][Full Text] [Related]
6. Characterization of C/EBPbeta isoforms in normal versus neoplastic mammary epithelial cells.
Eaton EM; Hanlon M; Bundy L; Sealy L
J Cell Physiol; 2001 Oct; 189(1):91-105. PubMed ID: 11573208
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle defects contribute to a block in hormone-induced mammary gland proliferation in CCAAT/enhancer-binding protein (C/EBPbeta)-null mice.
Grimm SL; Contreras A; Barcellos-Hoff MH; Rosen JM
J Biol Chem; 2005 Oct; 280(43):36301-9. PubMed ID: 16120603
[TBL] [Abstract][Full Text] [Related]
8. CCAAT/enhancer-binding protein beta inhibits proliferation in monocytic cells by affecting the retinoblastoma protein/E2F/cyclin E pathway but is not directly required for macrophage morphology.
Gutsch R; Kandemir JD; Pietsch D; Cappello C; Meyer J; Simanowski K; Huber R; Brand K
J Biol Chem; 2011 Jul; 286(26):22716-29. PubMed ID: 21558273
[TBL] [Abstract][Full Text] [Related]
9. C/EBPbeta-2 confers EGF-independent growth and disrupts the normal acinar architecture of human mammary epithelial cells.
Bundy L; Wells S; Sealy L
Mol Cancer; 2005 Dec; 4():43. PubMed ID: 16371159
[TBL] [Abstract][Full Text] [Related]
10. CCAAT/enhancer binding protein beta (C/EBPbeta)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture.
Bundy LM; Sealy L
Oncogene; 2003 Feb; 22(6):869-83. PubMed ID: 12584567
[TBL] [Abstract][Full Text] [Related]
11. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer.
Lamb J; Ramaswamy S; Ford HL; Contreras B; Martinez RV; Kittrell FS; Zahnow CA; Patterson N; Golub TR; Ewen ME
Cell; 2003 Aug; 114(3):323-34. PubMed ID: 12914697
[TBL] [Abstract][Full Text] [Related]
12. A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation.
Zahnow CA; Cardiff RD; Laucirica R; Medina D; Rosen JM
Cancer Res; 2001 Jan; 61(1):261-9. PubMed ID: 11196172
[TBL] [Abstract][Full Text] [Related]
13. CCAAT/enhancer binding protein beta (C/EBPβ) isoform balance as a regulator of epithelial-mesenchymal transition in mouse mammary epithelial cells.
Miura Y; Hagiwara N; Radisky DC; Hirai Y
Exp Cell Res; 2014 Sep; 327(1):146-55. PubMed ID: 24881817
[TBL] [Abstract][Full Text] [Related]
14. MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.
Johansson J; Berg T; Kurzejamska E; Pang MF; Tabor V; Jansson M; Roswall P; Pietras K; Sund M; Religa P; Fuxe J
Oncogene; 2013 Dec; 32(50):5614-24. PubMed ID: 23955085
[TBL] [Abstract][Full Text] [Related]
15. Examining the role of cyclin D1 in breast cancer.
Velasco-Velázquez MA; Li Z; Casimiro M; Loro E; Homsi N; Pestell RG
Future Oncol; 2011 Jun; 7(6):753-65. PubMed ID: 21675838
[TBL] [Abstract][Full Text] [Related]
16. CCAAT/enhancer binding protein β negatively regulates progesterone receptor expression in human glioblastoma cells.
Hansberg-Pastor V; González-Arenas A; Camacho-Arroyo I
Mol Cell Endocrinol; 2017 Jan; 439():317-327. PubMed ID: 27663075
[TBL] [Abstract][Full Text] [Related]
17. The role of C/EBPbeta in mammary gland development and breast cancer.
Grimm SL; Rosen JM
J Mammary Gland Biol Neoplasia; 2003 Apr; 8(2):191-204. PubMed ID: 14635794
[TBL] [Abstract][Full Text] [Related]
18. CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases.
Zahnow CA
Expert Rev Mol Med; 2009 Apr; 11():e12. PubMed ID: 19351437
[TBL] [Abstract][Full Text] [Related]
19. 1,25-Dihydroxyvitamin D3 induces monocytic differentiation of human myeloid leukemia cells by regulating C/EBPβ expression through MEF2C.
Zheng R; Wang X; Studzinski GP
J Steroid Biochem Mol Biol; 2015 Apr; 148():132-7. PubMed ID: 25448741
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of the endogenous C/EBPβ LIP isoform predisposes to tumorigenesis.
Bégay V; Smink JJ; Loddenkemper C; Zimmermann K; Rudolph C; Scheller M; Steinemann D; Leser U; Schlegelberger B; Stein H; Leutz A
J Mol Med (Berl); 2015 Jan; 93(1):39-49. PubMed ID: 25401168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
